pivekimab sunirine

After chat with FDA, ImmunoGen delays pivotal top-line data on blood cancer ADC to 2024
Fierce Biotech
Wed, 08/31/22 - 10:31 am
Immunogen
antibody drug conjugate
pivekimab sunirine
blood cancer